分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Up-regulation of MELK by E2F1 promotes the proliferation in cervical cancer cells

Hongzhi Sun, Hongmei Ma, Hao Zhang, Minjun Ji

Journal:International Journal of Biological Sciences

IF:6.58

DOI:10.7150/ijbs.62517

PMID:34671205

Published:2021-09-07

research field:肿瘤学分子生物学胃肠病学微生物学基因调控

Abstract

Cervical cancer is a common gynecologic cancer and a frequent cause of death. In this study, we investigated the role of MELK (maternal embryonic leucine zipper kinase) in cervical cancer. We found that HPV 18 E6/E7 promoted MELK expression by activating E2F1. MELK knockdown blocked cancer cells growth. Furthermore, we used MELK-8A to inhibit the kinase activity of MELK and caused the G2/M phase arrest of cancer cells. Under the treatment of inhibitors, Hela cells formed multipolar spindles and eventually underwent apoptosis. We also found that MELK is involved in protein translation and folding during cell division through the MELK interactome and the temporal proteomic analysis under inhibition with MELK-8A. Altogether, these results suggest that MELK may play a vital role in cancer cell proliferation and indicate a potential therapeutic target for cervical cancer.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用